Clinical evaluation of free PSA total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer

被引：14
|
作者：
Filella, X [1 ]
Alcover, J [1 ]
Molina, R [1 ]
Rodriguez, A [1 ]
Carretero, P [1 ]
Ballesta, AM [1 ]
机构：
[1] HOSP CLIN BARCELONA,DEPT UROL,BARCELONA 08036,SPAIN
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷 / 08期
关键词：
PSA; free PSA; prostate cancer;
D O I：
10.1016/S0959-8049(97)00081-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The objective of this study was to evaluate the utility of the free/total prostate-specific antigen (PSA) ratio (per cent free PSA) in the diagnosis of prostate cancer. Serum total PSA and free PSA concentrations were measured in 156 patients with benign prostate hyperplasia (BPH) and 74 patients with prostate cancer using Hybritech Tandem immunoradiometric assays. Patients with prostate cancer had a significantly lower free/total PSA ratio than patients with BPH, although the distributions across study groups overlapped. In patients with a total PSA level between 4 mu g/l and 25 mu g/l, free/total PSA demonstrated better diagnostic utility than total PSA alone. (C) 1997 Published by Elsevier Science Ltd.
引用
收藏
页码：1226 / 1229
页数：4
相关论文
共 50 条
  • [1] Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less
    Liu, Xin
    Tang, Jie
    Fei, Xiang
    Li, Qiu-Yang
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2015, 44 (11) : 1466 - 1472
  • [2] Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer
    VanCangh, PJ
    DeNayer, P
    Sauvage, P
    Tombal, B
    Elsen, M
    Lorge, F
    Opsomer, R
    Wese, FX
    [J]. PROSTATE, 1996, : 30 - 34
  • [3] Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening
    Reissigl, A
    Klocker, H
    Pointner, J
    Fink, K
    Horninger, W
    Ennemoser, O
    Strasser, H
    Colleselli, K
    Holtl, L
    Bartsch, G
    [J]. UROLOGY, 1996, 48 (6A) : 62 - 66
  • [4] Prostate-specific antigen: Importance of the free-to-total PSA ratio in the diagnosis of prostatic carcinoma
    Giannotti, P
    Cuttano, MG
    Paoluzzi, M
    De Maria, M
    Sicolo, M
    Santarcangelo, M
    Pazzagli, I
    Ferdeghini, M
    Mancini, P
    [J]. XI NATIONAL CONGRESS, 1997, : 453 - 455
  • [5] Analysis of percent free prostate-specific antigen (PSA) for prostate cancer detection: Influence of total PSA, prostate volume, and age
    Partin, AW
    Catalona, WJ
    Southwick, PC
    Subong, ENP
    Gasior, GH
    Chan, DW
    [J]. UROLOGY, 1996, 48 (6A) : 55 - 61
  • [6] Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: Which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer?
    Jung, K
    Elgeti, U
    Lein, M
    Brux, B
    Sinha, P
    Rudolph, B
    Hauptmann, S
    Schnorr, D
    Loening, SA
    [J]. CLINICAL CHEMISTRY, 2000, 46 (01) : 55 - 62
  • [7] Individual risk prediction of high grade prostate cancer based on the combination between total prostate-specific antigen (PSA) and free to total PSA ratio
    Ferraro, Simona
    Biganzoli, Davide
    Rossi, Roberta Simona
    Palmisano, Franco
    Bussetti, Marco
    Verzotti, Enrica
    Gregori, Andrea
    Bianchi, Filippo
    Maggioni, Marco
    Ceriotti, Ferruccio
    Cereda, Cristina
    Zuccotti, Gianvincenzo
    Kavsak, Peter
    Plebani, Mario
    Marano, Giuseppe
    Biganzoli, Elia Mario
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (07) : 1327 - 1334
  • [8] Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: Age-specific reference ranges for total PSA, free PSA, and percent free PSA
    Kalish, LA
    McKinlay, JB
    [J]. UROLOGY, 1999, 54 (06) : 1022 - 1027
  • [9] Prostate-specific antigen (PSA): A tumor marker in the diagnosis of prostate cancer
    Ohlendorf D.
    Wanke E.M.
    Braun M.
    Oremek G.M.
    Groneberg D.A.
    [J]. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 2017, 67 (4) : 221 - 223
  • [10] The clinical utility of measuring free-to-total prostate-specific antigen (PSA) ratio and PSA density in differentiating between benign prostatic hyperplasia and prostate cancer
    Kochañska-Dziurowicz, AA
    Mielniczuk, MR
    Stojko, A
    Kaletka, J
    [J]. BRITISH JOURNAL OF UROLOGY, 1998, 81 (06): : 834 - 838
12345